Florian Lordick: personal fees from Amgen, Astellas Pharma, AstraZeneca, Bayer, Biontech, Eli Lilly, Elsevier, Excerpta Medica, Imedex, Infomedica, Medscape, MedUpdate, Merck Serono, Merck Sharp & Dohme, Oncovis, Promedicis, Roche, Springer Nature, StreamedUp!, and Zymeworks; grants and personal fees from BMS outside the submitted work. Michael Ghadimi: nothing to disclose. Ines Gockel: nothing to disclose. Ullrich Graeven: honoraria from Sirtex Medical, Daiichi Sankyo, Boehringer Ingelheim, Amgen, Servier, AstraZeneca; consulting or advisory role for Merck KGaA, Bristol-Myers Squibb, Hexal, Amgen, Celgene, Johnson & Johnson, MSD Oncology; and travel/accommodation expenses from Merck KGaA, Amgen, Boehringer Ingelheim. C. Benedikt Westphalen: received personal and speaker fees, reimbursement for travel/accommodation, and honoraria for participance in advisory boards from Bayer, Celgene, Ipsen, MedScape, Rafael Pharmaceuticals, RedHill, Roche, Servier, Shire/Baxalta, and Taiho, and scientific grant support from Roche.